Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,455Revenue $M4,003Net Margin (%)4.1Z-Score3.2
Enterprise Value $M9,427EPS $-0.1Operating Margin %6.6F-Score7
P/E(ttm))48.5Cash Flow Per Share $4.7Pre-tax Margin (%)3.7Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %-8.7Quick Ratio1.6Cash flow > EarningsY
Price/Sales2.05-y EBITDA Growth Rate %-28.0Current Ratio2.6Lower Leverage y-yN
Price/Cash Flow6.8y-y EBITDA Growth Rate %174ROA % (ttm)2.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)5.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M169ROI % (ttm)-1.9Gross Margin Increase y-yY

Gurus Latest Trades with HSP

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
HSPMario Gabelli 2014-06-30 Add0.01%$42.14 - $52.41
($47.4)
$ 49.875%Add 32.91%204,370
HSPJohn Rogers 2014-06-30 Reduce-0.53%$42.14 - $52.41
($47.4)
$ 49.875%Reduce -24.15%3,130,809
HSPVanguard Health Care Fund 2014-03-31 Add0.18%$40.89 - $45
($42.83)
$ 49.8716%Add 22.69%8,375,170
HSPMario Gabelli 2014-03-31 Add0.01%$40.89 - $45
($42.84)
$ 49.8716%Add 30.68%153,770
HSPRichard Snow 2014-03-31 Sold Out -1.3%$40.89 - $45
($42.84)
$ 49.8716%Sold Out0
HSPBrian Rogers 2014-03-31 Sold Out -0.37%$40.89 - $45
($42.84)
$ 49.8716%Sold Out0
HSPJohn Rogers 2014-03-31 Reduce-0.28%$40.89 - $45
($42.84)
$ 49.8716%Reduce -11.62%4,127,850
HSPJohn Rogers 2013-12-31 Add0.12%$38.53 - $42.19
($40.25)
$ 49.8724%Add 5.28%4,670,630
HSPRichard Snow 2013-09-30 Reduce-0.85%$38.45 - $42.03
($39.88)
$ 49.8725%Reduce -36.89%811,590
HSPRichard Pzena 2013-09-30 Sold Out -0.27%$38.45 - $42.03
($39.88)
$ 49.8725%Sold Out0
HSPJohn Rogers 2013-09-30 Reduce-0.23%$38.45 - $42.03
($39.88)
$ 49.8725%Reduce -7.79%4,436,305
HSPJohn Rogers 2013-06-30 Add0.34%$30.57 - $38.31
($33.81)
$ 49.8748%Add 12.97%4,811,105
HSPBrian Rogers 2013-06-30 Add0.24%$30.57 - $38.31
($33.81)
$ 49.8748%Add 135.3%2,750,000
HSPRichard Snow 2013-06-30 Reduce-0.27%$30.57 - $38.31
($33.81)
$ 49.8748%Reduce -11.68%1,286,067
HSPMichael Price 2013-03-31 Add0.65%$28.96 - $35.99
($32.42)
$ 49.8754%Add 61.62%400,000
HSPVanguard Health Care Fund 2013-03-31 Add0.62%$28.96 - $35.99
($32.42)
$ 49.8754%Add 242.15%6,826,070
HSPJohn Rogers 2013-03-31 Add0.6%$28.96 - $35.99
($32.42)
$ 49.8754%Add 33.12%4,258,620
HSPRichard Snow 2013-03-31 Add0.34%$28.96 - $35.99
($32.42)
$ 49.8754%Add 17.2%1,456,133
HSPMeridian Funds 2013-03-31 Buy 0.28%$28.96 - $35.99
($32.42)
$ 49.8754%New holding, 237400 sh.237,400
HSPBrian Rogers 2013-03-31 Buy 0.15%$28.96 - $35.99
($32.42)
$ 49.8754%New holding, 1168700 sh.1,168,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

HSP is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
HSP Mario Gabelli 2014-06-30204,3700.120.06+32.91%
HSP Robert Bruce 2014-06-3010,0000.010.12
HSP Michael Price 2014-06-30400,0000.242.5
HSP Vanguard Health Care Fund 2014-06-308,375,1704.961.1
HSP John Rogers 2014-06-303,130,8091.862-24.15%
HSP Meridian Funds 2013-06-30257,4000.150.37+8.42%
Premium Most recent portfolio changes are included for Premium Members only!


HSP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Werner Thomas ESVP, Finance & CFO 2014-10-17Sell10,000$50.040.14view
Werner Thomas ESVP, Finance & CFO 2014-09-15Sell10,000$52.74-4.99view
Werner Thomas ESVP, Finance & CFO 2014-08-15Sell10,000$55.13-9.11view
Werner Thomas ESVP, Finance & CFO 2014-07-15Sell10,000$51.5-2.7view
Werner Thomas ESVP, Finance & CFO 2014-06-16Sell10,000$50.82-1.4view
Werner Thomas ESVP, Finance & CFO 2014-05-21Sell30,000$47.984.44view
CURRAN CONNIE RDirector 2014-05-16Sell2,000$47.445.63view
BOWLES BARBARA LDirector 2014-05-14Sell2,000$47.774.9view
Hoffman Richard JCVP, Controller & CAO 2014-05-13Sell15,000$48.074.24view
SMITH BRIAN JSVP and Special Counsel 2014-05-12Sell40,000$484.4view

Press Releases about HSP :

    Quarterly/Annual Reports about HSP:

    News about HSP:

    Articles On GuruFocus.com
    Jeff Auxier Second Quarter Shareholder Letter Aug 08 2014 
    Brian Rogers' T. Rowe Price Equity Income Fund Semi-Annual Report 2013 Dec 02 2013 
    Ariel Capital's John Rogers Trims Sotheby’s, DeVry, Hospira, IPG, Others Nov 18 2013 
    Five Companies Cut - Pzena Investment Management Update Nov 12 2013 
    John Rogers Comments on Hospira Inc. Jul 25 2013 
    Rowe Price Equity Income Fund Buys Apple, Carnival, Joy Global, Sells Thermo Fisher, Energizer, SLM Jul 19 2013 
    John Rogers Ariel Fund Second Quarterly Commentary Jul 18 2013 
    Brian Rogers' Top 3 Increases and Decreases of Q2 Jul 17 2013 
    comment on HSP May 22 2013 
    Brian Rogers of T Rowe Price Buys 4 New Stocks, Including Apple in Q1 Apr 17 2013 


    More From Other Websites
    Exclusive: Fresenius, buyout groups eye Danone Medical Nutrition unit - sources Oct 17 2014
    Fresenius, buyout groups eye Danone Medical Nutrition unit - sources Oct 17 2014
    HOSPIRA INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,... Oct 07 2014
    Hospira Gets FDA Warning Letter for Australian Facility Oct 06 2014
    Hospira to Host Conference Call for Third-Quarter 2014 Results Oct 06 2014
    [$$] Hospira Receives FDA Warning Letter Oct 01 2014
    HOSPIRA INC Files SEC form 8-K, Other Events Oct 01 2014
    CE Mark for Boston Scientific's Vercise in Essential Tremor Sep 17 2014
    Epirus, Ranbaxy win India approval for arthritis drug copy Sep 15 2014
    Burlington Stores, Quiksilver, Hospira, Mylan and Gilead Sciences highlighted as Zacks Bull and Bear... Sep 10 2014
    Hospira Down on Legal Blow; Court Allows Generic Precedex Sep 09 2014
    HOSPIRA INC Files SEC form 8-K, Regulation FD Disclosure, Other Events Sep 08 2014
    Hospira inversion talks paused Sep 03 2014
    Exclusive: Hospira talks with Danone on $5 billion tax inversion deal stall Sep 03 2014
    Exclusive - Hospira talks with Danone on $5 billion tax inversion deal stall Sep 03 2014
    [$$] Judge's Order Delays FDA Approval for Generic Form of Hospira Drug Aug 21 2014
    Tata Motors, Tupperware Brands, Hospira, Mylan and Mallinckrodt highlighted as Zacks Bull and Bear... Aug 21 2014
    HOSPIRA INC Files SEC form 8-K, Other Events Aug 20 2014
    Hospira Sues FDA on Generic Precedex Approval, Shares Down Aug 20 2014
    U.S. judge blocks FDA rule allowing generic versions of Hospira drug Aug 20 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK